Radiation Oncology

Urologic Oncology

Questions discussed in this category

How do you decide between internal versus external decompression of malignant obstruction of the ureter (MUO)?

How do you decide between ureteral stent and percutaneous nephrostomy for decompression?

Which patients with prostate cancer do you consider to be good candidates for salvage local treatment after radiation therapy?

How does time since radiation, original PSA and grade group/gleason score inform your decision?

2 Answers available

For a patient post-prostatectomy with a high PSA (>1), a negative MRI pelvis, and a negative PSMA PET scan, do you pursue any other imaging?

FDG PET, Axumin PET, Bone scan? Or just proceed with salvage ADT/RT?

4 Answers available

How would you manage a patient with PSA persistence after RALP demonstrating metastasis in regional lymph nodes without further evidence of disease on bone or CT scans?

Does performance status, age, or urinary incontinence after surgery affect your recommendations?

1 Answer available

Is there evidence that prostatectomy improves overall survival in local recurrence of prostate cancer post-definitive radiation?

3 Answers available

How do you manage favorable intermediate risk prostate cancer patients that have a PIRADS 5 lesion that was most-likely missed in the template biopsy?

For example, a patient that received an MRI after biopsy that demonstrates a PIRADS 5 lesion in anterior TZ which likely was not sampled on biopsy. Wo...

4 Answers available

Do you still order mpMRI for staging of prostate cancer in addition to PET-PSMA?

Which patients specifically benefit from both mpMRI and PET-PSMA?

4 Answers available

Is it appropriate to offer definitive trimodality therapy, as an equivalent option to neoadjuvant chemotherapy followed by radical cystectomy, in patients with muscle-invasive bladder cancer regardless of fitness or platinum eligibility?

Has this recent retrospective analysis published in Lancet Oncology changed your practice?

1 Answer available

In a patient with very high risk prostate cancer opting for prostatectomy, when, if ever, do you recommend neoadjuvant ADT?

4 Answers available

How would you approach a patient considered to be unfit for cystectomy with recurrent NMIBC refractory to BCG, failed pembrolizumab and unable to do more intravesical Rx?

2 Answers available

How would you approach treatment for a cT1N0M0 urothelial carcinoma of the ureter, high grade in a non-surgical candidate due to medical comorbidities?

2 Answers available

In a patient with otherwise low-risk prostate cancer, does presence of a small component of Grade Group 3 disease up-stage to unfavorable intermediate?

How would you treat such a patient?

3 Answers available

What chemotherapy do you use with radiation for urothelial carcinoma with squamous differentiation?

2 Answers available

Is there an absolute PSA level above which you would not recommend a radical prostatectomy for newly diagnosed prostate cancer despite the absence of metastatic disease with advanced imaging?

Are there other high or very high risk features that would also contribute to your decision making?

1 Answer available

Would you recommend surgery or radiation for newly diagnosed localized prostate cancer diagnosed on a urethral lesion biopsy?

GS 4+4. PSA low (1-2). CT and bone scan negative for lymphadenopathy or metastatic disease. Prostate MRI pending.

2 Answers available

Do you offer bladder-sparing approaches as an alternative to cystectomy for surgery-eligible patients with muscle-invasive bladder cancer?

Should cystectomy remain standard of care? (Recently debated in JAMA Oncology: http://jamanetwork.com/journals/jamaoncology/article-abstract/2520055...

1 Answer available

How do you approach isolated recurrence in a para-aortic lymph node following definitive radiation for localized prostate cancer?

Is there a role for salvage LN dissection or salvage RT to the node? And is there a role for systemic therapy (ADT or chemotherapy) in addition? If yo...

1 Answer available